Related Experiment Videos
[Pulmonary alveolar proteinosis].
M Sobiecka1, M Korzeniewska-Koseła, J Kuś
1I Kliniki Gruźlicy i Chorób Płuc Instytutu Gruźlicy, i Chorób Płuc w Warszawie.
Pneumonologia I Alergologia Polska
|March 30, 2001
Summary
Pulmonary alveolar proteinosis (PAP) is a rare lung disease. This review of 7 cases highlights its clinical features, diagnostic methods, and variable patient outcomes, including spontaneous remission and response to treatment.
Area of Science:
- Pulmonology
- Rare Diseases
- Respiratory Medicine
Background:
- Pulmonary alveolar proteinosis (PAP) is a rare condition characterized by surfactant accumulation in the lungs.
- Understanding the clinical spectrum and natural history of PAP is crucial for patient management.
Purpose of the Study:
- To evaluate the clinical features, diagnostic findings, and disease course of Pulmonary alveolar proteinosis.
- To assess treatment responses and spontaneous remission in PAP patients.
Main Methods:
- Retrospective review of 7 patients diagnosed with PAP between 1989 and 1999.
- Analysis of clinical presentations, lung function tests, imaging (X-ray, HRCT), and treatment outcomes.
Main Results:
- The study included 7 patients (2 female/5 male) with a mean age of 40.7 years.
- Common symptoms included dyspnea and cough; imaging revealed bilateral alveolar opacities and ground-glass opacities.
- Four patients experienced spontaneous partial remission, and 2 of 3 treated with bronchoalveolar lavage (BAL) improved.
Conclusions:
- Pulmonary alveolar proteinosis presents with diverse clinical and imaging findings.
- Spontaneous remission occurs in some patients, and bronchoalveolar lavage may be beneficial.